JAMS Third Issue Feb,2012
-
Upload
ismail-ibrahim -
Category
Documents
-
view
219 -
download
0
Transcript of JAMS Third Issue Feb,2012
-
8/2/2019 JAMS Third Issue Feb,2012
1/42
-
8/2/2019 JAMS Third Issue Feb,2012
2/42
JAMS, team and board 2
Elixir of youth 5
Wallenberg syndrome 7
stem cells and heart valve replacement 9
Cell phones may be carcinogenic 11
Medical news 13
Nano medicine and its Uses 17
Medical technology 21
How food affects your moods 23
Clinical trials 26
Screening for nutritional risk among elderly population 27
Your way to USA 30
Nobel prize in Medicine 34
Case report 37
Case discussion 40
1Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
3/42
Welcome to JAMS the first medical journal designed to be fromstudents to students. JAMS is a platform for medical students to
share & present medical articles about all what is new in medicine,articles written in simple & attractive way
Vision:
Journal of Alexandria Medical students is the first medical journal inAlexandria, even in Egypt designed to be from students to students. Our
vision is to make JAMS one of the important medical student journal in
Egypt and worldwide aiming to raise the Alexandria medical students'scientific level.
Mission:
Our mission is to provide a platform for medical students to share &present their medical articles... We had a "board of supervisors" from
our dear professors who support us and guide us to make good scientific
workWe publish our JAMS as online version in private site which islinked to Alexandria faculty of medicine site and as board version under
the Academic building in the faculty and as hard-copy version that will
be in the hand of every medical student and doctor.
Objectivs:
1. To provide a medium for Alexandria medical students to publish theirwork and share ideas with their peers.2.To provide a suitable forum for students to make the transitionbetween assignment-writing and producing publishable academic
work.
3.To inform students about medical topics and issues not typicallyaddressed in core curricula.
4.To facilitate discussion of current issues relevant to medical students.5.To foster the next generation of Alexandria medical researchers and
physician-scientists.
2Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
4/42
Mohammed Abd Elfattah
mohammed DarweshFifth Year Medicine (Undergraduate)Faculty of medicine, Alexandria University
Mohammed Mostafa Abd
El-HameedFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Mohammed Sabry RostomFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Yehia Attito MohamedFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Mohammed Abd-Rabboh
Attia BadaweyFifth Year Medicine (Undergraduate)Faculty of medicine, Alexandria University
Mohamed Abd El-Moneim
GhonaimFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Amr El-DaqaqFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Mai Al KosiryFifth Year Medicine (Undergraduate)
Faculty of medicine, Alexandria University
Jams team at the opening ceremony
3Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
5/42
Prof. Ashraf Saad Galal
Dean and Professor of Ophthalmology
Prof. Mahmoud El-Zalabany
Ex.dean and professor of pediatrics
Prof. Abd El-Aziz Belal
Ex .Dean and Professor of ENTProf. Yasser Mazloum
Professor of RadiologyProf. Samir Naeem
Professor of Endocrinology
Prof. Samir Helmy Asaad
Professor of Diabetes & Metabolism
Prof. Osamah Ebadaa
Professor of gastroenterology
Prof. Salah abd El-Meneem
Professor of Oncology
Prof. Fathy Elsewy
Professor of diabetes and metabolism
Prof. Mahmoud IBRAHIM
Professor of chest and sleep disorders
Prof. Mahmoud Hassanein
Professor of Cardiology
Prof. Osamah Ebadah
Professor of gastroenterology
Prof. Maha Hegazy
Professors of Physiology
Prof. Gehan Gewevel
Professor of community medicine
Assist. Prof. Hisham El-
Shishtawy
Professors of psychiatry
Assist. Prof. Nihal El
Habachi
Professors of Physiology
Assist. Prof. Ayman El-
ShayebProfessor of Tropical medicine
Board of supervisors
4Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
6/42
By:Ahmed MustafaSixth year medicine (undergraduate)
According to
Greek mythology
the goddess Hebe
was the Goddess of
youth, she was
typically depicted
in Greek and
Roman works of art
as being young and
attractive, wearing
a sleeveless dress
and bearing a
pitcher or pitchers
that were alleged
to contain an elixir that could restore of
maintain a persons youthfulness.
Man was always fascinated by the idea of
eternal youth; In Euripides' play Heracleidae,
Hebe helped Iolaus to achieve that dream.
Herodotus mentioned a fountain containing
a very special kind of water located in the
land of the Ethiopians, he called it the
fountain of youth!! . The eastern versions of
the Alexander romance, which describes
Alexander the Great and his servant crossing
the Land of Darkness to find the restorative
spring, also revolved around the same idea.
If youth means a long healthy life then now
we really have a hope to make that true!!
Its the same way of science that tells you
you can really change cupper to gold if
someday you can perfectly understand and
used the nuclear science science may not beas exciting as the myth but at least it can give
you a solid profound truth to use!!!
Well the story of our drug, or Elixir if you
like!! , started by a paradox; Dr. Serge
Renaud, a scientist from Bordeaux University
in France in 1992, noticed that the although
the French people consume more saturated
fats than most of other nations they have
relatively low incidence of coronary heart
disease and to the surprise the incidence was
lower in the red wine consumers .
There were many
theories but a 1997
study reporting on
the potential
anticancer activity
of trans-resveratrol
spurred interest in
resveratrol as a
nutritional supplement. Resveratrol is a
substance found in large quantities in thetraditional Japanese and Chinese medicinal
herb Polygonum cuspidatum. It also occurs
naturally in grape skin extracts, red wine,
purple grape juice, peanuts, mulberries,
blueberries, and bilberries.
That attention driven by that study to
resveratrol led to further studies that showed
that resveratrol has cardioprotective,immunologic, antiplatelet, anti-
inflammatory, anticancer actions and
antiaging actions!!. Much interest has
evolved around resveratrol's potential for
improving brain and cardiovascular health.
Some of the observations of a protective
effect on brain health came from the
association between red-wine consumption
and lower incidence of dementia andAlzheimer's disease; clearance of brain
amyloid peptides by resveratrol in vitro has
5Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
7/42
been claimed as a mechanism for improved
cognitive function in humans. In severalstudies resveratrol was found to activate
sirtuins, a family of seven enzymes
associated with the aging process.
In 2003 Howitz and Sinclair, the co-
discoverers of sirtuins, reported in the
journal Nature that resveratrol significantly
extends the lifespan of the yeast
Saccharomyces cerevisiae. Later studies
revealed that resveratrol also prolongs the
lifespan of the worm Caenorhabditis elegans
and the fruit fly Drosophila melanogaster.
We know, thanks to Sinclair, that calorie
restriction can activate sirtuins in mice .In
2006 a team led by Baur and Paerson
published a study on nature that showed that
resveratrol mimic that effect on mice and can
prevent adverse metabolic effect of high
calorie diet.
This all seems to be very promising but
definitive human clinical trials supporting its
protective benefits (short or long term)
against Alzheimer's disease, cardiovascular
disease, and cancer are lacking. Most of
these studies were in vitro studies or on
animals.
We still have to wait
for confirmation by
clinical trials for EBM
to approve usingresveratrol as Elixir
of youth. Ad lib use
of it as a supplement
is not advised.
Consuming food
containing resveratrol
may seem appealing
but keep in mind that you have to consume
enormous amount of grapes or mulberry toget a dose equivalent to that used in the
experiments.
Fortunately red wine is not an option in our
religion and society and even though you
also need massive amount of wine that
alcohol would destroy your liver on your
quest for health!!!
The bottom line for this is that we all believe
in science and its ability to conquer all the
obstacles so lets keep our fingers crossed
that resveratrol would soon be available
after finishing its trials and in the mean while
eat balanced healthy diet and dont follow
every hype.
References:
Baur JA, Pearson KJ, Price NL, et al.Resveratrol improves health and survival of
mice on a high-calorie diet. Nature 2006;
DOI:10.1038/nature05354
Dsire Lie. Resveratrol -- Apocryphal Claimor Promise?. Medscape clinical cases;
October 2009
Sue Hughes. Substance found that canprolong healthy life in mice. Heartwire;November 3, 2006
6Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
8/42
By: Nora Hassan Abd Abd ElkawySixth year medicine (undergraduate)
Definition:
Wallenberg syndrome is a condition that
affects the nervous system. It is often caused
by a brain stem stroke. Symptoms may
include swallowing difficulty, hoarseness,
dizziness, nausea, vomiting, quick involuntary
eye movements (nystagmus), balance andcoordination problems and Horner
syndrome.
Wallenberg syndrome caused by
multiple sclerosis mimicking stroke
Wallenberg syndrome (WS), also known as
lateral medullary syndrome, is a well-
characterised brainstem syndrome that was
first described in 1895 by Dr Wallenberg. Thecomplete spectrum of WS symptoms and
signs includes vertigo, nausea and vomiting,
dysphagia, hiccoughs, nystagmus, ataxia,
ipsilateral facial spinothalamic sensory loss
(due to inclusion of the spinal trigeminal
tract) with contralateral body spinothalamic
hemianaesthesia, and ipsilateral Horners
sign. Incomplete forms of WS occur
frequently, presenting with various
combinations of these clinical signs.
Aetiology
The most common aetiology of WS is stroke due
to occlusion of the vertebral or posterior inferior
cerebellar arteries. However, non-vascular
disorders can also be the underlying cause for
WS, as has been reported in the literature. In
Western countries multiple sclerosis (MS) is a
common inflammatory demyelinating disorder of
the central nervous system. In most patients,
with the help of MRI and other investigations, MS
can be distinguished from ischaemic stroke
without difficulty. Occasionally, however, when it
presents more acutely, MS may be misdiagnosed
as stroke.
Case report:
A 52-year-old Caucasian woman was
admitted to our Neurology Unit. She first felt
tired and unwell on the day of presentationand went to bed with a mild throbbing
headache, which progressively worsened
over the next 30 minutes. After an hour she
developed vomiting and loss of balance on
walking. On admission, she was alert and
oriented. The general physical examination
was unremarkable. Neurological examination
revealed incomplete WS, including torsional
nystagmus in all directions, partial left
Horners sign, pain and temperature sensorydeficit of the left side of her face and the
right side of her body, and positive
Rombergs sign with falling to the left. There
were no bulbar symptoms. Motor
examination of all four limbs was normal. Her
past medical history included very occasional
migraines (three in her lifetime),
hypothyroidism and type 2 diabetes, the
latter being well controlled with oral
metformin (500 mg twice daily). She denied
any antecedent vascular events and reported
no family history of neurological disorders.
7Journal of Alexandria Medical Students
http://www.nlm.nih.gov/medlineplus/ency/article/000708.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000708.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000708.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000708.htm -
8/2/2019 JAMS Third Issue Feb,2012
9/42
Fig. 2. (A) Axial and (B) sagittal T2-weighted MRI of the whole spine on two
weeks after admission showing evolution in the lateral medullary lesion,
typical of multiple sclerosis
An emergency cerebral MRI scan performed
after symptom onset revealed a recent left
medulla oblongata lesion, which hadrestricted diffusion on diffusionweighted
imaging (DWI; Fig. 1). Routine biochemical
investigations were normal. The patient was
diagnosed as having acute left lateral
medullary infarction with incomplete WS
and was commenced on aspirin (150 mg per
day) and atorvastatin (80 mg twice daily).
However, as the cerebral MRI had also
demonstrated some atypical lesions in the
subcortical white matter, the diagnosis of MSwas not excluded. After discharge from
hospital, the patient had persisting loss of
walking balance, nausea and anorexia. She
later recalled an episode of some electrical
sensations passing into both arms 6 months
previously, consistent with Lhermittes
phenomenon, which resolved within several
days. An MRI of the whole spinal cord was
subsequently performed, and revealed
an upper cervical cord lesion typical of
demyelinating disease. The images also
revealed evolution in the lateral
medullary lesion that furtherstrengthened the diagnosis of MS (Fig.
2). She was readmitted to hospital 1
month later, for further diagnosis and
treatment. The neurological
examination revealed bilateral
horizontal nystagmus, a wide-based
gait with falling to the left, and a
positive Rombergs sign. The other
neurological signs had since resolved.
Routine biochemistry tests and additionalautoantibody studies were normal. A
diagnosis of definite MS was made based on
McDonald criteria (two relapses and lesions
at two different anatomical sites). The
patient recovered slowly, and treatment with
interferonb-1a was initiated.
On a follow-up assessment, a repeat cerebral
MRI performed 3 months later showed a new
lesion in the right frontal white matter, a new
corpus callosum lesion and radiologicalevolution of the medullary lesion diagnostic
of MS. However, the patient has not
experienced any further clinical relapses
during the follow-up period of almost two
years. A recent cerebral MRI scan did not
demonstrate any new lesions, and the
dorsolateral medullary lesion had
significantly reduced in size.
References
1. NINDS Wallenberg's Syndrome Information Page.National Institute of Neurological Disorders and Stroke
(NINDS). February 15, 2007
2. Love BB, Biller J. Textbook of Clinical Neurology,3rd ed. In: Neurovascular System. Philadelphia,
PA:Saunders; 2007
3. Pryse-Phillips W, Murray TJ. Textbook of PrimaryCare Medicine, 3rd ed. In: . Clinical ischemic stroke
syndromes. Philadelphia, PA:Mosby, Inc; 2001
4. Wei Qiu, Jing-Shan Wu, William M. Carroll, FrankL. Mastaglia, Allan. Kermode,* Wallenberg syndrome
caused by multiple sclerosis mimicking stroke. CaseReports / Journal of Clinical Neuroscience 16 ; 2009:
17001702
Fig. 1. Cerebral axial (A) T2-weighted and (B) diffusion-weighted MRI
erformed at initial admission showin a left dorsal lateral medullar lesion
8Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
10/42
By: Norhan Mostafa HamzaThird year medicine (undergraduate)
Blood is pumped in heart through the cham-
bers, aided by four heart valves (the mitral
valve, tricuspid valve, pulmonary valve and the
aortic valve). The valves open and close to let
the blood flow in only one direction.
So when a valve is said to be defec-
tive?
A defective heart valve is one that fails tofully open or close as it should normally do,
this defective valve may be:
A stenotic heart valve can't open com-pletely, so blood is pumped through a
smaller-than-normal opening.
A valve also may not be able to closecompletely. This leads to regurgitation
(blood leaking back through the valve
when it should be closed).
What can cause a defective heart
valve? A person can be born with an abnormal
heart valve, a type of congenital heart de-
fect
Also it can be damaged by:1. Infections such as infective endocarditis.2. Rheumatic fever.3. Changes in valve structure in the elderly.
How can we treat a defective heart
valve?
People with congenital heart valve defects
may need treatment with drugs while Some
valve defects may be repaired with surgery,
researches have been carried to use a new
technology in treating defective heart valves
& prevent the complications of surgeries ,thisnew technology is using stem cells.
What are stem cells?
Stem cellsare cells found in all multi cellu-
lar organisms. They are characterized by the
ability to renew themselves through mitot-
ic cell division and differentiate into a diverse
range of specialized cell types.
What is the aim of recent carried
researches?
A British research team led by the world's
leading heart surgeon has grown part of a
human heart from stem cells for the first
time. If animal trials scheduled for later this
year prove successful, replacement tissue
could be used in transplants for the hundreds
of thousands of people suffering from heart
disease within three years.
9Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
11/42
Growing replacement tissue from stem cells is
one of the principal goals of biology. If a dam-
aged part of the body can be replaced by tissue
that is genetically matched to the patient, thereis no chance of rejection.
What is the progress of these re-
searches so far?
So far, scientists have grown tendons, cartilag-
es and bladders, but none of these has the
complexity of organs.
How the British research teamheaded by Professor MagdiYacoub
is trying to crack the problem?
Prof.Yacoub assembled a team of physicists,
biologists, engineers, pharmacologists, cellular
scientists and clinicians. Their task to character-
ize how every bit of the heart works has taken
10 years.
Prof.Yacoub said his team's latest work had
brought the goal of growing a whole, beating
human heart closer. "It is an ambitious project
but not impossible. The progress of nowadays
all over the world makes us believe that this
new this technology will be applied sooner than
we imagine.
What is Professor Magdi Yacoubs opinion about
the project?
If that trial works well, Prof.Yacoub is opti-
mistic that the replacement heart tissue,
which can be grown into the shape of a hu-
man heart valve using specially-designed col-
lagen scaffolds, could be used in patients
within three to five years.
Growing a suitably-sized piece of tissue
from a patient's own stem cells would take
around a month but he said that most people
would not need such individualized treat-
ment. A store of ready-grown tissue made
from a wide variety of stem cells could pro-
vide good matches for the majority of the
population.
Finally, we hope that this new technology
works out so that everybody can breathe air
and pump blood.
References:
http://www.guardian.co.uk/science/2007/apr/02/stemcells.genetics
http://www.heart-valve-surgery.com/heart-surgery-blog/2007/09/04/stem-cells-and-heart-valve-replacements/
http://stemcells.nih.gov/info/basics/basics1.asp Google images
10Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
12/42
By:Jehan Magdy MoharramSixth year medicine (undergraduate)
The World Health Organization (WHO)
announced that radiation from cell phones
can possibly cause cancer. According to the
WHO's International Agency for Research on
Cancer (IARC), radiofrequency electro-
magnetic fields have been classified as
possibly carcinogenic to humans (group 2B)
on the basis of an increased risk for glioma
that some studies have associated with the
use of wireless phones.
Human exposures to RF-EMF (frequency
range 30 kHz300 GHz) can occur from use
of personal devices (eg, mobile telephones,
cordless phones, Bluetooth, and amateur
radios), from occupational sources (eg, high-
frequency dielectric and induction heaters,
and high-powered pulsed radars)
For workers, most exposure to RF-EMFcomes from near-field sources, whereas the
general population receives the highest
exposure from transmitters close to the
body, such as handheld devices like mobile
telephones.
The most important factors that determine
the induced fields are the distance of the
source from the body and the output power
level. Additionally, the efficiency of coupling
and resulting field distribution inside the
body strongly depend on the frequency,
polarisation, and direction of wave incidence
on the body, and anatomical features of the
exposed person, including height, body-mass
index, posture, and dielectric properties of
the tissues. Induced fields within the body
are highly non-uniform, varying over several
orders of magnitude, with local hotspots.
Holding a mobile phone to the ear to make
a voice call can result in high specific RF
energy absorption-rate (SAR) values in the
brain, depending on the design and positionof the phone and its antenna in relation to
the head, how the phone is held, the
anatomy of the head, and the quality of the
link between the base station and phone.
When used by children, the average RF
energy deposition is two times higher in the
brain and up to ten times higher in the bone
marrow of the skull, compared with mobile
phone use by adults
Use of hands-free kits lowers exposure to the
brain to below 10% of the exposure from use
at the ear, but it might increase exposure to
other parts of the body.
Epidemiological evidence for an association
between RF-EMF and cancer comes from
cohort, case-control, and time-trend studies.
The populations in these studies were
exposed to RF-EMF in occupational settings,
from sources in the general environment,and from use of wireless (mobile and
cordless) telephones, which is the most
extensively studied exposure source. One
cohort study and five case-control
studies were judged by the Working Group to
offer potentially useful information regarding
associations between use of wireless phones
and glioma.
References:
The lancet oncology,Published Online: 22 June
2011
11Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
13/42
Guidelines of article submission:
Pages:one page for board, not more than three pages for online version, up tofive pages for in-depth window.
Size: A4 document. Language: English Title:interesting, clear, related to the topic. Content: clear, concise, interesting, only in medical field, updated and
undergraduate level.
Editing:1. Microsoft Word 97-2003 (*.doc) or 2007-2010 (*.docx) format.2. At least one picture related to the topic.3. Two columns.4. 12-point sized font.5. "Calibri" font.6. Leave a blank line after each new paragraph.7. Margins of 2.5cm on all sides.8. Orientation "Portrait".9. Revised well No Misspelled words.
References: should be listed inthe order in which they first appear in thearticle refer to the website
The publishable articles will be reviewed by the "board ofsupervisors"
Of course, you can share with us with medical comics, crosswords,
medical "do you know?" medical notes and case discussion.
Address: Alexandria Faculty of Medicine - Azarita - Alexandria Egypt.
Website:www.jams-online.com
Email:[email protected]
Facebook group:Journal of Alexandria Medical Students
12Journal of Alexandria Medical Students
http://c/Users/M.A.A.B/Desktop/2nd%20issue/www.jams-online.comhttp://c/Users/M.A.A.B/Desktop/2nd%20issue/www.jams-online.comhttp://c/Users/M.A.A.B/Desktop/2nd%20issue/www.jams-online.commailto:[email protected]:[email protected]:[email protected]://www.facebook.com/pages/Journal-of-Alexandria-Medical-Students/231574336860054http://www.facebook.com/pages/Journal-of-Alexandria-Medical-Students/231574336860054http://www.facebook.com/pages/Journal-of-Alexandria-Medical-Students/231574336860054http://www.facebook.com/pages/Journal-of-Alexandria-Medical-Students/231574336860054mailto:[email protected]://c/Users/M.A.A.B/Desktop/2nd%20issue/www.jams-online.com -
8/2/2019 JAMS Third Issue Feb,2012
14/42
By: Mohamed GhonaimSixth year medicine (undergraduate)
Stem Cell Therapy May ReverseDiabetes :
An immune regulator from healthy cord
blood stem cells (CB-SCs) can "educate" the Tcells of a person with type 1 diabetes (T1D),
enabling the pancreas to produce insulin,
according to a report published
online January 10, 2012, in BMC Medicine.
Researchers base their "stem cell educator
therapy" on observations that multipotent
stem cells from human cord blood can alter
regulatory T cells (Tregs) and islet B cell
specific T-cell clones. The new approach
alters autoimmunity both in non-obese
diabetic mice and in islet B cells from patients
with diabetes. In a small, open-label trial, a
single treatment reduced the median daily
dose of required insulin and some B-cell
function; the researchers circulated
lymphocytes from patients' blood in a closed-
loop "stem cell educator," co-culturing the
cells for 2 to 3 hours with adherent CB-SCs
from healthy donors. The investigators
infused the "educated"lymphocytes into the
patients and measured
both levels of C-
peptide and glycated
hemoglobin and
indicators of immune
function at 4, 12, 24,
and 40 weeks. The
treated individualsdisplayed better C-
peptide and glycated
hemoglobin A1c values,
lower daily
requirement for insulin, and decreased
autoimmunity.
Patients with T1D had improved fasting C-
peptide levels & fall of Hb A1c levels .Stemcell education significantly increased the
percentage of Tregs in peripheral blood. The
CB-SCs produce an autoimmune regulator
which may eliminate autoreactive T cells.This
innovative approach may provide CB-SC-
mediated immune modulation therapy for
multiple autoimmune diseases while
mitigating the safety and ethical concerns
associated with other approaches.
Breast Cancer Vaccine ShowsPromising Results :
(CBS) A vaccine to prevent breast cancer
has shown favorable results in animals, they
found that a single vaccination with the
antigen a-lactalbumin prevents breast cancer
tumors from forming in mice, while inhibitingthe growth of existing tumors.
13Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
15/42
In the current study, genetically cancer-
prone mice were
vaccinated half with a
vaccine containing the
antigen and vaccine thatdid not contain the
antigen. None of the
mice vaccinated with
the antigen developed
breast cancer, while the
other entire mice did.
The key is to find a
target within the tumor
that isn't typically found in a healthy person.
In the case of breast cancer, researchers
team targeted a-lactalbumin, a protein found
in the majority of breast cancers, but not in
healthy women, except during lactation.
Therefore, the vaccine can rev up a woman's
immune system to target a-lactalbumin,
stopping tumor formation without damaging
healthy breast tissue. While the researchers
are optimistic, they warn it's a big leap from
results in animals to similar results in humans
and there is no guarantee the treatment will
make it to human trials.
Red Meat Consumption LinkedWith Risk for Kidney Cancer :
People who eat lots of red meat may have a
higher risk of some types
of kidney cancer,
suggests a large U.S.
study performed onclose to 500,000 U.S.
adults age 50 and older,
who were surveyed on
their dietary habits,
including meat
consumption, and then
followed for an average
of nine years. When the
researchers found that the association
between red meat and cancer was stronger
for papillary cancers, but there was no effect
for clear-cell kidney cancers. People who ate
the most well-done grilled and barbecued
meat -- and therefore had the highest
exposure to carcinogenic chemicals from the
cooking process -- also had an extra risk of
kidney cancer compared to those who didn't
eat meat cooked that way. support the
dietary recommendations for cancer
prevention currently put forth by the
American Cancer Society -- limit intake of red
and processed meats and prepare meat by
cooking methods such as baking and
broiling."
New Class of Drug May VanquishCLL:
Navitoclax, a novel BH3 mimetic that
blocks the function of BCL-2, has shown
significant antileukemic activity in patients
with chronic lymphocytic leukemia (CLL) in a
phase 1 trial published in the Journal of
Clinical Oncology. "Navitoclax works in CLL
14Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
16/42
because it stops the function of BCL-2, and
CLL cells are very dependent on BCL-2 to stay
alive. BCL-2 also helps CLL and other cancer
cells resist standard chemotherapy, so
inhibiting BCL-2 can lead to the CLL cellsdying or being set up to die if another stress
such as additional chemotherapy is added.
Adverse events were diarrhea, nausea,
vomiting, fatigue, and neutropenia, which
occurred in 10% or more of the patients.
Tamiflu-Resistant Influenza VirusSpreading in Australia
A variation of the pandemic 2009 A(H1N1)
influenza virus that is resistant to oseltamivir
(Tamiflu, Roche) appears to be spreading in
Australia, In the Australian study, 29 (16%) of
182 patients infected with the pandemic
influenza virus between May 2011 and
August 2011 harbored a version of the virus
that was oseltamivir-resistant. the
oseltamivir-resistant virus is detected in less
than 1% of patients with the pandemic 2009
A(H1N1) virus who have not been treated
previously with the antiviral. In addition,
transmission has been documented only in
closed settings suggesting the spread of a
single variant. Although the virus was
resistant to oseltamivir, it was still
susceptible to the antiviral medication
zanamivir.The authors write that as the
Northern Hemisphere heads into winter,
public health authorities there should rapidly
analyze pandemic virus strains from the
outset to determine whether an oseltamivir-
resistant version is spreading.
Researchers Report PositiveResults in Malaria Vaccine Study :
In the war against a disease killed almost
800,000 people in one year (2009) . A vaccine
candidate being studied in phase 3 clinical
trials in 7 African countries involving 15,460
children has prevented half of the potential
malaria cases among 1 group of the study
population; the vaccine candidate, RTS,
S/AS01, is a hybrid combining the hepatitis B
antigen with part of the protein called
sporozoite, the infective form of the malaria
parasite. In earlier studies, RTS,S/AS01
showed consistent protection
against Plasmodium falciparum, the most
serious form of malaria, and showed a 45.1%
(CI, 23.8% - 60.5%) improvement in the
intention-to-treat population in the current
results. However, the results also showed
that the level of protection from the vaccine
was lower after the first year than
immediately after vaccination. The authors
write that studies have shown different
results for protection levels and that this calls
for further investigation.
15Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
17/42
Future researcher project
What is the future research
project?
It is the first project to be conducted by
JAMS and it is concerned with teaching
undergraduates the basic skills of Research
works organized in 11 sessions (for example:
How to write a research proposal?,
Evidence based medicine, clinical trials,
evidence-based medicine,..etc.), by
agreeing with members of the teaching staff
in Alexandria faculty of medicine who areinterested in holding such workshops.
Every session will be composed of:
Lecture. Training. Group discussion.
First, they can participate with
postgraduates in their research work as coresearchers.
Future research project is collaboration
between JAMS and AMSRA (Alexandria
medical student research association) whichaims at:
1. Increasing the participation of
undergraduate students in research
projects.
2. Improvement of research skills amongst
undergraduate students.
3. Preparing undergraduate students for
their postgraduate studies through their
early exposure to research activity.
4. Increasing communication between the
students and their teaching staff and
postgraduate researchers.
Finally, there will be good researchers that
will publish their research papers in JAMS
and other medical journals and share themwith their peer.
16Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
18/42
BY: Amr El-Daqaq
Sixth year medicine (undergraduate)
Nanomedicine is the medi-cal application of nanotechnol-
ogy. Nanomedicine ranges from
the medical applications of na-
nomaterials, to nanoelectronic
biosensors, and even possible
future applications of molecularnanotechnology. Current prob-
lems for nanomedicine involve
understanding the issues relat-
ed to toxicity and environmen-
tal impact of nanoscale materi-
als.
Medical use of nanomaterials
Two forms of nanomedicine that have al-
ready been tested in mice and are awaiting
human trials are using gold nanoshells to
help diagnose and treat cancer, and using
liposomes as vaccine adjuvants and as vehi-
cles for drug transport.
1-Drug delivery:
Nanomedical approaches to drug deliverycenter on developing nanoscale particles or
molecules to improve drug bioavailability.
Bioavailability refers to the presence of
drug
molecules where they are needed in the
body and where they will do the most good.
Drug delivery focuses on maximizing bioa-
vailability both at specific places in the body
and over a period of time. This can
potentially be achieved by molecular target-
ing by nanoengineered devices. It is all about
targeting the molecules and delivering drugs
with cell precision. More than $65 billion are
wasted each year due to poor bioavailability.
The strength of drug delivery systems is their
ability to alter the pharmacokinetics and bio-
distribution of the drug. Nanoparticles have
unusual properties that can be used to im-
prove drug delivery. Where larger particles
would have been cleared from the body, cells
take up these nanoparticles because of theirsize. Complex drug delivery mechanisms are
being developed, including the ability to get
drugs through cell membranes and into cell
cytoplasm. Efficiency is important because
many diseases depend upon processes within
the cell and can only be impeded by drugs
that make their way into the cell. Potential
nanodrugs will work by very specific and
well-understood mechanisms; one of the ma-jor impacts of nanotechnology and
17Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
19/42
nanoscience will be in leading development
of completely new drugs with more useful
behavior and less side effects.
2-In vivo imaging:
Nanoimaging is another area where tools
and devices are being developed. Using na-
noparticle contrast agents, images such as
ultrasound and MRI have a favorable distri-
bution and improved contrast. What nano-
scientists will be able to achieve in the future
is beyond current imagination. This might be
accomplished by self-assembled biocompati-
ble nanodevices that will detect, evaluate,
treat and report to the clinical doctor auto-
matically.
3-Nano & Cancer:
The small size of nanoparticles endows
them with properties that can be very useful
in oncology, particularly in imaging. Quantum
dots (nanoparticles with quantum
confinement properties, such as size-tunable
light emission), when used in conjunction
with MRI (magnetic resonance imaging), can
produce exceptional images of tumor sites.
These nanoparticles are much brighter than
organic dyes and only need one light source
for excitation. This means that the use of flu-
orescent quantum dots could produce a
higher contrast image and at a lower cost
than todays organic dyes used as contrast
media. The downside, however, is that quan-
tum dots are usually made of quite toxic el-
ements.
Another nanoproperty, high surface area to
volume ratio, allows many functional groups
to be attached to a nanoparticle, which can
seek out and bind to certain tumor cells. Ad-
ditionally, the small size of nanoparticles (10
to 100 nanometers), allows them to
preferentially accumulate at tumor
sites (because tumors lack an effec-
tive lymphatic drainage system). A
very exciting research question is
how to make these imaging nano-
particles do more things for cancer.
For instance, is it possible to manu-
facture multifunctional nanoparti-
cles that would detect, image, and
then proceed to treat a tumor? This
question is under vigorous investiga-
tion; the answer to which could
shape the future of cancer treat-
ment. A promising new cancer
treatment that may one day replace
radiation and chemotherapy is edging closer
to human trials. Kanzius RF therapy attaches
microscopic nanoparticles to cancer cells and
then "cooks" tumors inside the body with
18Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
20/42
radio waves that heat only the nanoparticles
and the adjacent (cancerous) cells.
Researchers at Rice University under Prof.
Jennifer West, have demonstrated the use of
120 nm diameter nanoshells coated with
gold to kill cancer tumors in mice. The
nanoshells can be targeted to bond to can-
cerous cells by conjugating antibodies or
peptides to the nanoshell surface. By irradiat-
ing the area of the tumor with an infrared
laser, which passes through flesh without
heating it, the gold is heated sufficiently to
cause death to the cancer cells.
4- Nano & Surgery:
At Rice University, a flesh welder is used to
fuse two pieces of chicken meat into a single
piece. The two pieces of chicken are placed
together touching. A greenish liquid contain-
ing gold-coated nanoshells is dribbled along
the seam. An infrared laser is traced along
the seam, causing the two sides to weld to-
gether. This could solve the difficulties and
blood leaks caused when the surgeon tries to
restitch the arteries that have been cut dur-
ing a kidney or heart transplant. The flesh
welder could weld the artery perfectly.
5- Nanonephrology:
Nanonephrology is a branch of nanomedi-cine and nanotechnology that deals with 1)
the study of kidney protein structures at the
atomic level; 2) nano-imaging approaches to
study cellular processes in kidney cells; and
3) nano medical treatments that utilize na-
noparticles and to treat various kidney dis-
eases. The creation and use of materials
and devices at the molecular and atomic
levels that can be used for the diagnosis and
therapy of renal diseases is also a part of
Nanonephrology that will play a role in the
management of patients with kidney diseasein the future. Advances in Nanonephrology
will be based on discoveries in the above ar-
eas that can provide nano-scale information
on the cellular molecular machinery involved
in normal kidney processes and in pathologi-
cal states. By understanding the physical and
chemical properties of proteins and other
macromolecules at the atomic level in vari-
ous cells in the kidney, novel therapeutic ap-proaches can be designed to combat major
renal diseases. The nano-scale artificial kid-
ney is a goal that many physicians dream of.
Nano-scale engineering advances will permit
programmable and controllable nano-scale
robots to execute curative and reconstructive
procedures in the human kidney at the cellu-
lar and molecular levels. Designing
nanostructures compatible with the kidney
cells and that can safely operate in vivo is al-
so a future goal. The ability to direct events
in a controlled fashion at the cellular nano-
level has the potential of significantly improv-
ing the lives of patients with kidney diseases.
19Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
21/42
6-Cell repair machines:
Using drugs and surgery, doctors can only
encourage tissues to repair themselves. With
molecular machines, there will be more di-
rect repairs. Cell repair will utilize the same
tasks that living systems already prove possi-
ble. Access to cells is possible because biolo-
gists can insert needles into cells without kill-
ing them. Thus, molecular machines are ca-
pable of entering the cell.
Also, all specific biochemical interactionsshow that molecular systems can recognize
other molecules by touch, build or rebuild
every molecule in a cell, and can disassemble
damaged molecules. Finally, cells that repli-
cate prove that molecular systems can as-
semble every system found in a cell. There-
fore, since nature has demonstrated the
basic operations needed to perform molecu-
lar-level cell repair, in the future, na-
nomachine based systems will be built that
are able to enter cells, sense differences from
healthy ones and make modifications to the
structure.
The healthcare possibilities of these cell re-
pair machines are impressive. Comparable to
the size of viruses or bacteria, their
compact parts would allow them to be more
complex. The early machines will be special-
ized. As they open and close cell membranes
or travel through tissue and enter cells and
viruses, machines will only be able to correct
a single molecular disorder like DNA damage
or enzyme deficiency. Later, cell repair ma-
chines will be programmed with more abili-
ties with the help of advanced AI systems.
Nanocomputers will be needed to guide
these machines. These computers will direct
machines to examine, take apart, and rebuild
damaged molecular structures. Repair ma-
chines will be able to repair whole cells by
working structure by structure. Then by
working cell by cell and tissue by tissue,
whole organs can be repaired. Finally, by
working organ by organ, health is restored to
the body. Cells damaged to the point of inac-
tivity can be repaired because of the ability
of molecular machines to build cells from
scratch. Therefore, cell repair machines will
free medicine from reliance on self-repair
alone.
20Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
22/42
By: Mohammed Abd-RabbohSixth year medicine (undergraduate)
About 15 years ago, MIT professors Robert
Langerand Michael Cima had the idea to devel-
op a programmable, wirelessly controlled
microchip that would deliver drugs after implan-
tation in a patients body. This week, the MIT
researchers and scientists from Chips Company
reported that they have successfully used such a
chip to administer daily doses of an osteoporo-
sis drug normally given by injection.
The results, published in the Feb. 16 online
edition of Science Translational Medicine,
represent the first successful test of such a
device and could help usher in a new era of
telemedicine delivering health care over a
distance, Langer says.
You could literally have a pharmacy on a
chip, says Langer, the David H. Koch Institute
Professor at MIT. You can do remote control
delivery, you can do pulsatile drug delivery,
and you can deliver multiple drugs.
In the new study, scientists used the pro-
grammable implants to deliver an osteoporosis
drug called teriparatide to seven women aged
65 to 70. The study found that the device deliv-
ered dosages comparable to injections, and
there were no adverse side effects.
These programmable chips could dramatically
change treatment not only for osteoporosis, but
also for many other diseases, including cancer
and multiple sclerosis. Patients with chronic
diseases, regular pain-management needs or
other conditions that require frequent or daily
injections could benefit from this technology,
says Robert Farra, president and chief operating
officer at MicroCHIPS and lead author of the
paper.
Compliance is very important in a lot of drug
regimens, and it can be very difficult to getpatients to accept a drug regimen where they
have to give themselves injections, says Cima,
the David H. Koch Professor of Engineering at
MIT. This avoids the compliance issue com-
pletely, and points to a future where you have
fully automated drug regimens.
Achievingprecision
The MIT research team started working on the
implantable chip in the mid-1990s. John Santini,
then a University of Michigan undergraduate
visiting MIT, took it on as a summer project
under the direction of Cima and Langer. Santini,
who later returned to MIT as a graduate student
to continue the project, is also an author of the
new paper.
21Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
23/42
In 1999, the MIT team published its initial
findings in Nature, the company was founded
and licensed the microchip technology from
MIT. The company refined the chips, includingadding a hermetic seal and a release system
that works reliably in living tissue. Teripar-
atide is a polypeptide and therefore much less
chemically stable than small-molecule drugs,
so sealing it hermetically to preserve it was an
important achievement, Langer says.
The human clinical trial began in Denmark in
January 2011. Chips were implanted during a
30-minute procedure at a doctors office using
local anesthetic, and remained in the patients
for four months. The implants proved safe, and
patients reported they often forgot they even
had the implant, Cima says.
Chips used in the study stored 20 doses of
teriparatide, individually sealed in tiny reser-
voirs about the size of a pinprick. The reservoirs
are capped with a thin layer of platinum and
titanium that melts when a small electrical
current is applied, releasing the drug inside. The
company is now working on developing im-
plants that can carry hundreds of drug doses per
chip.
Because the chips are programmable, dosages
can be scheduled in advance or triggered re-
motely by radio communication over a special
frequency called Medical Implant Communica-
tion Service (MICS). Current versions work over
a distance of a few inches, but researchers plan
to extend that range.
Consistent results
In the Science Translational Medicine study,
the researchers measured bone formation in
osteoporosis patients with the implants, and
found that it was similar to that seen in patients
receiving daily injections of teriparatide. Anoth-
er notable result is that the dosages given by
implant had less variation than those given byinjection.
Henry Brem, professor of neurosurgery, oph-
thalmology, oncology and biological engineering
at Johns Hopkins University School of Medicine,
called the results stunning.
Its very rare to find a paper that is really a
breakthrough in technology, says Brem, who
was not part of the research team.It fulfills the promise of polymer drug delivery and the
incredible sophistication of microchip capabili-
ties.
Once a version of the implant that can carry a
larger number of doses is ready, the company
plans to seek approval for further clinical trials,
Farra says. The company has also developed a
sensor that can monitor glucose levels. Eventu-ally such sensors could be combined with chips
that contain drug reservoirs, creating a chip that
can adapt drug treatments in response to the
patients condition.
References:
Published in Science Translational MedicineRapid Publica-
tion on February 16 2012
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3003276
22Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
24/42
BY: Mohammed Sabry RostomSixth year medicine (undergraduate
Can your diet really help put you in a good
mood? And can what you choose to eat or
drink encourage bad moods or mild depres-
sion?
While certain diets or foods may not
ease depression (or put you instantly in a
better mood), they may help as part of anoverall treatment plan. There's more and
more research indicating that, in some ways,
diet may influence mood. We don't have the
whole story yet, but there are some interest-
ing clues.
Basically the science of food's effect on
mood is based on this: Dietary changes can
bring about changes in our brain structure
(chemically and physiologically), which can
lead to altered behavior.
How Can You Use Food to Boost Mood?
So how should you change your diet if you
want to try to improve your mood? You'll
find eight suggestions below. Try to incorpo-
rate as many as possible, because regardless
of their effects on mood, most of these
changes offer other health benefits as well.
1. Don't Banish Carbs -- Just Choose 'Smart'
Ones
The connection between carbohydrates
and mood is all about tryptophan, a nones-
sential amino acid. As more tryptophan en-
ters the brain, more serotonin is synthesized
in the brain, and mood tends to improve.
Serotonin, known as a mood regulator, is
made naturally in the brain from tryptophan
with some help from the B vitamins. Foods
thought to increase serotonin levels in the
brain include fish and vitamin D.
Here's the catch, though: While tryptophan
is found in almost all protein-rich foods, oth-
er amino acids are better at passing from the
bloodstream into the brain. So you can actu-
ally boost your tryptophan levels by eating
more carbohydrates; they seem to help elim-
inate the competition for tryptophan, so
more of it can enter the brain. But it's im-
portant to make smart carbohydrate choiceslike whole grains, fruits, vegetables, and leg-
umes, which also contribute important nutri-
ents and fiber.
So what happens when you follow a very
low carbohydrate diet? According to re-
searchers from Arizona State University, a
very low carbohydrate (ketogenic) diet was
found to enhance fatigue and reduce the de-
sire to exercise in overweight adults after just
two weeks.
2. Get More Omega-3 Fatty Acids
In recent years, researchers have noted
that omega-3 polyunsaturated fatty acids
(found in fatty fish, flaxseed, and walnuts)
may help protect against depression.
23Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
25/42
This makes sense physiologically, since
omega-3s appear to affect neurotransmitter
pathways in the brain. Past studies have sug-
gested there may be abnormal metabolism
of omega-3s in depression, although some
more recent studies have suggested there
may not be a strong association between
omega-3s and depression. Still, there are
other health benefits to eating fish a few
times a week, so it's worth a try. Shoot for
two to three servings of fish per week.
3. Eat a Balanced Breakfast
Eating breakfast regularly leads to im-
proved mood, according to some researchers-- along with better memory, more energy
throughout the day, and feelings of calm-
ness. It stands to reason that skipping break-
fast would do the opposite, leading to fatigue
and anxiety. And what makes up a good
breakfast? Lots of fiber and nutrients, some
lean protein, good fats, and whole-grain car-
bohydrates.
4. Keep Exercising and Lose Weight (Slowly)
After looking at data from 4,641 women
ages 40-65, researchers from the Center for
Health Studies in Seattle found a strong link
between depression and obesity, lower phys-
ical activity levels, and a higher calorie intake.
Even without obesity as a factor, depression
was associated with lower amounts of mod-
erate or vigorous physical activity. In many of
these women, I would suspect that depres-
sion feeds the obesity and vice versa.
Some researchers advise that, in overweight
women, slow weight loss can improve mood.
Fad dieting isn't the answer, because cutting
too far back on calories and carbohydrates
can lead to irritability. And if you're following
a low-fat diet, be sure to include plenty of
foods rich in omega-3s (like fish, ground flax-
seed, higher omega-3 eggs, walnuts, and
canola oil.)
5. Move to a Mediterranean Diet
The Mediterranean diet is a balanced,
healthy eating pattern that includes plenty of
fruits, nuts, vegetables, cereals, legumes, andfish -- all of which are important sources of
nutrients linked to preventing depression.
A recent Spanish study, using data from
4,211 men and 5,459 women, showed that
rates of depression tended to increase in
men (especially smokers) as folate intake de-
creased. The same occurred for women (es-
pecially among those who smoked or werephysically active) but with another B-vitamin:
B12. This isn't the first study to discover an
association between these two vitamins and
depression.
Researchers wonder whether poor nutrient
intake may lead to depression, or whether
depression leads people to eat a poor diet.
Folate is found in Mediterranean diet staples
like legumes, nuts, many fruits, and particu-
larly dark green vegetables. B-12 can be
found in all lean and low-fat animal products,
such as fish and low-fat dairy products.
6. Get Enough Vitamin D
Vitamin D increases levels of serotonin in
the brain but researchers are unsure of the
individual differences that determine how
much vitamin D is ideal (based on where you
live, time of year, skin type, level of sun ex-posure). Researchers from the University of
Toronto noticed that people who were suf-
fering from depression, particularly those
with seasonal affective disorder, tended to
improve as their vitamin D levels in the body
increased over the normal course of a year.
Try to get about 600 international units (IU)
of vitamin D a day from food if possible.
24Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
26/42
7. Select Selenium-Rich Foods
Selenium supplementation of 200 mi-
crograms a day for seven weeks improved
mild and moderate depression in 16 elderly
participants, according to a small study from
Texas Tech University. Previous studies have
also reported an association between low
selenium intakes and poorer moods.
More studies are needed, but it can't hurt
to make sure you're eating foods that help
you meet the Dietary Reference Intake for
selenium (55 micrograms a day). It's possible
to ingest toxic doses of selenium, but this isunlikely if you're getting it from foods rather
than supplements.
Foods rich in selenium are foods we should
be eating anyway such as:
Seafood (oysters, clams, sardines, crab,saltwater fish and freshwater fish)
Nuts and seeds (particularly Brazil nuts) Lean meat (lean pork and beef, skinless
chicken and turkey)
Whole grains (whole-grain pasta, brownrice, oatmeal, etc.)
Beans/legumes Low-fat dairy products8. Don't Overdo Caffeine
In people with sensitivity, caffeine may ex-
acerbate depression. (And if caffeine keeps
you awake at night, this could certainly affect
your mood the next day.) Those at risk could
try limiting or eliminating caffeine for a
month or so to see if it improves mood.
References:
Maes, M. Psychiatry Research, March22, 1999; vol 85: pp 275-291.
Appleton, K.M. Journal of AffectiveDisorders, Dec. 2007; vol 104: pp
217-223.
Medical Journal of Australia, Nov. 6,2000; 173 Suppl: S104-5. White A.M.
Journal of the American Dietetic As-
sociation, October 2007; vol 107: pp
1792-1796.
Sanchez-Villegas, PublicHealth Nutrition, 2006; vol 9: pp
1104-9. Simon, G.E. General Hospital
Psychiatry, Jan-Feb 2008; vol 30: pp
32-9.
Weiss, C.J. Journal of the AmericanDietetic Association, August 2005; vol
105: p 26.
25Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
27/42
Dr. Nihal El Habachi
ASS. Prof. of Physiology and Director of Alex. CRC
Protocol
The study plan on which aclinical research study is based.
It is carefully designed to answerspecific research questions.
What types of people mayparticipate, the schedule
of tests, procedures,
medications, dosages, the
length of the study, etc.
Research Studies Versus Clinical
Care
It is important to distinguishbetween:
Research AND Clinical Care. Research Subjects VS.
Patients.
The purpose of clinical care is totreat the individual patient while
that of research studies is to
gainknowledge that can be
generalized to groups of people. Research studies differ from
clinical care in three ways:
Follow a protocol. Collect data to be analyzed to
find answers to a Research
question.
May not always benefit theindividual.
Regulation of clinical
research
FOOD AND DRUG
ADMINISTRATION (FDA) The U.S. federal oversight
agency responsible for
protecting the public health by
assuring the safety, efficacy and
security of human and
veterinary drugs, biological
products, medical devices, food
supply, cosmetics, and products
that emit radiation.
Good Clinical Practice (GCP)
International ethical and scientificquality standards for designing,
conducting, recording, and
reporting trials that involve the
participation of human subjects
Purpose:Provides public assurance that the
rights, safety, and well-being of
study subjects are protected,
consistent with the principals that
have their origin in the
Declaration of Helsinki, and that
the clinical data are credible.
To be continued Keep in
Touch
26Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
28/42
Older adults are a potentially vulnerable group for malnutri-
tion, especially the newly hospitalized elderly patients or those
institutionalized. Thus, the prevention of nutritional problems
is crucial.
Aim of the work: To assess the risk of malnutrition using the
Mini-Nutritional Assessment (MNA) among three groups of el-
derly people; institutionalized, hospitalized and freely living
outpatient groups.
Methods: A total of 300 persons (100 in each group) aged 65
years and over participated in the study. MNA questionnaire,anthropometrics (Body Mass index, mid arm circumference and
Calf circumference) were used to collect data.
The sensitivity and specificity of the MNA test were assessed
using the Body Mass Index as the gold standard.
Results:According to MNA score (maximum 30 points), MNA
30) was reg-
istered in 47% of insti-
tutionalized elderly versus
44% and 40% of elderly in
hospital and community
dwelling respectively , this
differences could be at-
tributed to the limited mobil-
ity of elderly in institutions
and hospitals as compared to
the independent persons of
the community.
On the other hand, only 5%
of institutionalized elderly
and 8% of hospitalized had a
BMI index of less than 20.
27Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
29/42
According to MNA, higher per-
centages of malnutrition were
found among these two groups
(10% and 28% respectively). It
was previously stated by
McWhirter and Pennington in
1994 that BMI alone is not a sen-
sitive indicator of protein-energy
malnutrition as it does not distin-
guish between depletion of fat or
muscle. It was also proved in the
present study that the MNA test
had a high sensitivity in this
population for detection of mal-
nutrition as compared to the BMI measure.
Moreover, the MNA had detected a high
percentage of at risk patients among the
hospitalized group (43%) and relatively lower
percentages among the outpatient (18%) and
institutionalized (10%) groups.
Recent research has shown that whilst the
prevalence of malnutrition in the free-living
elderly population is low (3-6 %), the risk ofmalnutrition increases in the institutionalized
elderly, and on admission to hospital.
The MNA has been used to screen elderly
people for malnutrition in different settings
and countries. Review of many studies con-
ducted to assess the malnutrition problem in
elderly using the MNA test had shown wide
range of prevalence of malnutrition in differ-
ent settings. In elderly institutions, from 12previous studies a mean prevalence of 37%
(range 5-71%) for malnutrition was detected
using the MNA and 44% (range 26-67%) at
risk of under-nutrition were detected.
The large variability results mainly from the
differences in level of dependence and health
status among the elderly living in retirement
homes, nursing homes, or long-term care fa-
cilities and communities differences.In the present study, the lower figure of
malnutrition (10%) and/or the percentage of
persons at risk (10%) in the institutionalizedgroup, as compared to the previous studies,
could be related to the admission policy in
these institutions in Alexandria where they
only accept apparently healthy residents ex-
cluding those diseased or who are in need of
medical care.
In elderly from 8 previous studies using
MNA assessment , the mean prevalence of
malnutrition was 1% in community-dwellingelderly persons, 4% (range 0-13%) in outpa-
tients, and a prevalence of 33% (ranges 8-
63%) for elderly who were at risk for malnu-
trition .
Comparatively, the prevalence of malnutri-
tion among the outpatient group in the pre-
sent study is considered within the minimal
figures reported previously; however, 18%
were at risk for malnutrition. Similarly, a min-
imal level of 1% as malnourished was classi-fied by MNA in a European community dwell-
ing sample of elderly persons.
Malnutrition is highly prevalent in hospital-
ized patients. Despite this, it is not routinely
assessed in most hospitals worldwide. One of
the reasons that might explain this fact is
that there is no gold-standard nutritional as-
sessment tool, and much has been written
advocating this or that technique. Several
studies have recently reinforced the relation-
ship between poor nutritional status and
28Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
30/42
higher incidences of
complications, mortali-
ty, length of hospital
stay and costs. There-
fore, it is of the utmost
importance to be able
to diagnose malnutri-
tion early.
In hospital settings, A
high prevalence of un-
der nutrition has been
reported in elderly pa-
tients. In elderly from
10 studies a prevalenceof 20% (range 7-32%)
of malnutrition was
detected (using the
MNA tool) and 49% (range 25-60%) were at
risk of under nutrition and a low MNA score
was common. In the present study, the prev-
alence of malnutrition in the hospitalized
group (28%) as well as the prevalence of
those at risk (43%) was more or less at the
same level as the previously mentioned stud-ies.
Medication goes hand in hand with chronic
disease: chronically ill patients will probably
have medication. Chronic diseases can affect
energy intake and contribute to poor nutri-
tional status.
The attendants of the outpatient clinic the
university hospital are poor patients whocannot afford the animal proteins in contrast
to the institutionalized elderly persons who
stated during their interview that they had
three meals and animal protein was served
daily. Thus, the habit to eat all foods served
at meals could be related to the better die-
tary criteria shown in this group as compared
to the outpatient group.
Increased age and female fender were sig-nificantly associated with poor nutritional
states.
Conclusion
Hospitalized subjects were characterized by
the worst nutritional status in comparison to
the other two groups in MNA test .where
43% were at risk of malnutrition and 28%were malnourished with a mean MNA score
of 16.962.97. All underweight subjects (BMI
-
8/2/2019 JAMS Third Issue Feb,2012
31/42
By: Mohammed Abd-RabbohSixth year medicine (undergraduate)
Overview:
U.S. residency programs
offer an excellent
opportunity for aspiring
doctors from around the
world to further their
education and gain
excellent experience.There are roughly 8,000
residency programs in the
United States. While this
process might seem quite
daunting, a basic
understanding of the different testing,
evaluation and matching processes will help
you advise students on how best to navigate
the path to a successful residency. Whatfollows is a step-by-step explanation of the
basic process.
We will illustrate the way to US in fivesteps as following :
Step 1 Complete the ECFMG Application:
The first step in the process is for students
to apply to the Educational Commission for
Foreign Medical Graduates (ECFMG,
www.ecfmg.org ) for a USMLE/ECFMG
Identification Number. Because of the variety
of educational standards, curricula, and
evaluation methods across the world, the
Accreditation Council for Graduate Medical
Education (ACGME) requires a standardized
testing procedure for all international
applicants. Be sure to familiarize yourself
with the information available on the ECFMG
website. The website provides the eligibility
requirements for starting the certification
process and walks you through the process of
applying for the required exams online
through an Interactive Web Application. Theexams are offered a number of times
throughout the year and are described in
more detail below.
Step 2Take USMLE:
What is USMLE?USMLE is abbreviation of United States
Medical Licensing Examination, and it is athree-step examination for medical licensure
in the United States and is sponsored by the
Federation of State Medical Boards (FSMB)
and the National Board of Medical Examiners
(NBME).
Students must have completed at least
three years of medical school to apply for any
of the required USMLE exams, which include
the Step 1 Medical Sciences exam and the
Step 2 Clinical Knowledge (CK) and Clinical
30Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
32/42
Skills (CS) Exams. These same tests are also
administered to graduates of U.S. and
Canadian medical schools. The Step 1 exam is
aimed at testing genera! Scientific
knowledge: whereas Step 2 assesses a
student's ability to put this knowledge into
practice with a patient. Students should also
refer to the ECFMG Information Booklet tosee whether these exams can be substituted
with any of the medical science exams they
have taken previously. All three tests must be
passed within a seven-year period; if all three
are passed, results do not expire. The Step 1
and Step 2 CK Exams are administered
worldwide at Thomson Prometric test
centers. The Clinical Skills exam must be
taken in the United States. Students must
obtain a scheduling permit from ECFMG to
register and schedule the test date with
Prometric.
The USMLEs three Steps:-
Step 1 An eight-hour, computer-based,
multiple-choice exam that assesses whether
you understand and can apply importantconcepts of the sciences basic to the practice
of medicine, with special emphasis on
principles and mechanisms underlying
health, disease, and modes of therapy.
Step 1 ensures mastery of not only the
sciences that provide a foundation for the
safe and competent practice of medicine inthe present, but also the scientific principles
required for the maintenance of competence
through lifelong learning. It includes test
items in the following content areas:
Anatomy. Behavioral sciences. Biochemistry.
Microbiology. Pathology. Pharmacology. Physiology. Interdisciplinary topics, such as
nutrition, genetics, and aging.
It costs about $930 when taken in Egypt.Step 2 assesses whether you can apply
medical knowledge, skills, and understanding
of clinical science essential for the provision
of patient care under supervision and
includes emphasis on health promotion and
disease prevention. Step 2 ensures that due
attention is devoted to principles of clinical
sciences and basic patient-centered skills
that provide the foundation for the safe and
competent practice of medicine. I t consists
of Step2 clinical knowledge (CK) and step 2
clinical skills (CS).
Step 2 (CK) A nine-hour, computer-based,
multiple choice exam that covers clinical
science including diagnosis and management
principles It includes test items in the
following content areas:
Internal medicine. Obstetrics and gynecology. Pediatrics.
31Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
33/42
Preventive medicine. Psychiatry. Surgery. Other areas relevant to provision of
care under supervision.
It costs about $945 when taken in Egypt.Step 2 (CS): It assesses whether you can
demonstrate the fundamental clinical skills
essential for safe and effective patient care
under supervision.
The day-long exam must be taken at
regional clinical skills evaluation center in theUnited States, it consists of twelve fifteen-
minute examinations of standardized
patients, with ten minutes to compose a
written record of the encounter (patient
note), there will be also encounter via
telephone.
There are three subcomponents of Step 2
(CS): Integrated Clinical Encounter (ICE),
Communication and Interpersonal Skills (CIS),and Spoken English Proficiency (SEP).
It costs about $1375.Step 3 assesses whether you can apply
medical knowledge and understanding of
biomedical and clinical science essential for
the unsupervised practice of medicine, with
emphasis on patient management in
ambulatory settings. Step 3 provides a final
assessment of physicians assuming
independent responsibility for delivering
general medical care.
It costs about $745. You dont have to take step 3 for applying
for residency program.
Step 2Apply to residency program:
After passing the required exams and
achieving ECFMC certification, students can
apply to the residency programs of their
choice through the Electronic Residency
Application Service (ERAS). Applications are
submitted during September.ERAS is a service developed by the
Association of American Medical Colleges
(AAMC) to transmit residency applications,
letters of recommendation, dean's letters,
transcripts and other supporting documents
to residency program directors, and after
reviewing the applications the national
residency match program (NRMP, the main
residency match results) will be available in
December.
Then admissions officers invite select
applicants for interviews, which typically take
place during November, December and
January. Here, admissions officers further
evaluate applicants based on the general
competencies required of residents: patient
care, medical knowledge, practice-based
learning and improvement, interpersonal and
Journal of Alexandria Medical Students 32Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
34/42
communication skills, professionalism, and
systems-based practice.
Because these programs are highly
selective, it is wise for students to spend time
researching all the potential residencies thatwould be a good fit given their academic
background and professional goals. The
Graduate Medical Education Directory
(Green Book) and the Accreditation Council
for Graduate Medical Education (ACGME) are
good resources for this research.
Step 4 Match with a Program:In February or March, following the
interview process, both applicants and
programs rank each other through the
National Resident Matching Program
(NRMP), a service which provides an
impartial venue for matching the preferences
of applicants and programs. In March of
2008, 15,242 graduates of American medical
schools and 4,650 graduates of non-U.S.
medical schools were matched to a first year
If residency position. The positions that are
not filled in the initial match process are then
listed on the NRMP website. These positions
can be filled in as quickly as an hour.
Note: All dates are subject to change.Step 5Obtain a Visa:
Following acceptance, medical schools send
accepted students an information packet,contract, and temporary license. The J1 visa
is the typical visa for residents although some
applicants are able to acquire an H-1B visa if
they have taken Step 3 of the USMLE tests or
apply for a waiver program to work for two
years in an underserved area after their
residency. Once the final certifications have
passed between the student, the interlocutor
agencies and the medical program, students
should contact their U.S. Embassy or
Consulate to set up a visa interview and
inquire about all of the documents required
for theirvisa.
Tips for you:How to prepare for a successful residencyinterview?
Call the program secretary to check for
current doctors from your own country or
region in order to connect with someone
currently involved with the program.
Study the program's website. Familiarize
yourself with the faculty - their professional
backgrounds, areas of expertise, andinvolvement in educational and training
programs.
Clearly communicate personal goals during
the interview.
Present previous experiences in an
articulate and organized fashion.
Send a thank you note after the interview
to express continued interest in the program.
How to find a residency program that will bebest fit?
Do not limit yourself to one specialty area.
Conduct through research on alternative
fields that may be of interest.
Remember that certain specialties tend to
be more competitive than others. Programs
such as internal medicine, pediatrics and
family medicine take only three years and are
less competitive, while specialties such as
surgery, ophthalmology, cardiology and
psychiatry are more competitive and require
additional time.
Talk to as many current residents as
possible. Find out if you click with them.
Lastly, I want to say that the purpose ofthis window is not to emigrate from
Egypt but to come back and improve thehealth care system and provide better
health to the Egyptian people.
33Journal of Alexandria Medical Students
https://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttp://www.unitedstatesvisas.gov/http://www.unitedstatesvisas.gov/http://www.unitedstatesvisas.gov/http://www.unitedstatesvisas.gov/https://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdfhttps://www.acgme.org/acWebsite/dataBook/2010-2011_ACGME_Data_Resource_Book.pdf -
8/2/2019 JAMS Third Issue Feb,2012
35/42
By: Mohammed Abd El-Fattah
Sixth Year Medicine (Undergraduate)
In 2011, Nobel Laureates have
revolutionized our understanding of the
immune system by discovering key principles
for its activation.
Scientists have long been searching for thegatekeepers of the immune response by
which man and other animals defend
themselves against attack by bacteria and
other microorganisms. Bruce Beutler and
Jules Hoffmann discovered receptor proteins
that can recognize such microorganisms and
activate innate immunity, the first step in the
bodys immune response. Ralph Steinman
discovered the dendritic cells of the immune
system and their unique capacity to activateand regulate adaptive immunity, the later
stage of the immune response during which
microorganisms are cleared from the body.
The discoveries of the three Nobel Laureates
have revealed how the innate and adaptive
phases of the immune response are activated
and thereby provided novel insights into
disease mechanisms. Their work has opened
up new avenues for the development ofprevention and therapy against infections,
cancer, and inflammatory diseases.
Two lines of defense in the
immune systemWe live in a dangerous world. Pathogenic
microorganisms (bacteria, virus, fungi, and
parasites) threaten us continuously but weare equipped with powerful defense
mechanisms. The first line of defense, innate
immunity, can destroy invading micro-
organisms and trigger inflammation that
contributes to blocking their assault. If
microorganisms break through this defense
line, adaptive immunity is called into action.
With its T and B cells, it produces antibodies
and killer cells that destroy infected cells.
After successfully combating the infectiousassault, our adaptive immune system
maintains an immunologic memory that
allows a more rapid and powerful
mobilization of defense forces next time the
same microorganism attacks. These two
defense lines of the immune system provide
good protection against infections but they
also pose a risk. If the activation threshold is
too low, or if endogenous molecules can
activate the system, inflammatory diseasemay follow.
The 2011 Nobel Prize in Physiology or Medicine
34Journal of Alexandria Medical Students
-
8/2/2019 JAMS Third Issue Feb,2012
36/42
The components of the immune system
have been identified step by step during the
20th century. Thanks to a series of
discoveries awarded the Nobel Prize; we
know, for instance, how antibodies areconstructed and how T cells recognize
foreign substances. However, until the work
of Beutler, Hoffmann and Steinman, the
mechanisms triggering the activation of
innate immunity and mediating the
communication between innate and adaptive
immunity remained enigmatic.
Discovering the sensors of innate
immunity
Jules Hoffmann made his pioneering
discovery in 1996, when he and his co-
workers investigated how fruit flies combat
infections. They had access to flies with
mutations in several different genes including
Toll, a gene previously found to be involved
in embryonal development by Christiane
Nsslein-Volhard (Nobel Prize 1995). When
Hoffmann infected his fruit flies with bacteria
or fungi, he discovered that Toll mutants died
because they could not mount an effective
defense. He was also able to conclude that
the product of the Toll gene was involved in
sensing pathogenic microorganisms and Toll
activation was needed for successful defense
against them.
Bruce Beutler was searching for a receptor
that could bind the bacterial product,
lipopolysaccharide (LPS), which can causeseptic shock, a life threatening condition that
involves overstimulation of the immune
system. In 1998, Beutler and his colleagues
discovered that mice resistant to LPS had a
mutation in a gene that was quite similar to
the Toll gene of the fruit fly. This Toll-like
receptor (TLR) turned out to be the elusive
LPS receptor. When it binds LPS, signals are
activated that cause inflammation and, when
LPS doses are excessive, septic shock. Thesefindings showed that mammals and fruit flies
use similar molecules to activate innate
immunity when encountering pathogenic
microorganisms. The sensors of innate
immunity had finally been discovered.
The discoveries of Hoffmann and Beutler
triggered an explosion of research in innateimmunity. Around a dozen different TLRs
have now been identified in humans and
mice. Each one of them recognizes certain
types of molecules common in micro-
organisms. Individuals with certain mutations
in these receptors carry an increased risk of
infections while other genetic variants of TLR
are associated with an increased risk for
chronic inflammatory diseases.
A new cell type that controls
adaptive immunityRalph Steinman discovered, in 1973, a new
cell type that he called the dendritic cell. He
speculated that it could be important in the
immune system and went on to test whether
dendritic cells could activate T cells, a cell
type that has a key role in adaptive immunity
and develops an immunologic memory
against many different substances. In cellculture experiments, he showed that the
presence of dendritic cells resulted in vivid
responses of T cells to such substances.
These findings were initiall